[go: up one dir, main page]

NI200700039A - DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS. - Google Patents

DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS.

Info

Publication number
NI200700039A
NI200700039A NI200700039A NI200700039A NI200700039A NI 200700039 A NI200700039 A NI 200700039A NI 200700039 A NI200700039 A NI 200700039A NI 200700039 A NI200700039 A NI 200700039A NI 200700039 A NI200700039 A NI 200700039A
Authority
NI
Nicaragua
Prior art keywords
triazolopiridinilsulfanilo
quinasa
inhibitors
map
derivatives
Prior art date
Application number
NI200700039A
Other languages
Spanish (es)
Inventor
John Paul Mathias
David Simon Millan
Russell Andrew Lewthwaite
Christopher Phillips
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NI200700039A publication Critical patent/NI200700039A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de fórmula (I), o un sal y/o solvato (incluyendo un hidrato) farmacéuticamente aceptable del mismo; y el uso de un compuesto de fórmula (I) en el tratamiento de una enfermedad, trastorno o afección mediada por TNF, o una enfermedad, trastorno o afección mediada por p38, en particular las enfermedades alérgicas y no alérgicas de las vías respiratorias, más particularmente enfermedades obstructivas o inflamatorias de las vías respiratorias, preferiblemente la enfermedad pulmonar obstructiva crónica.A compound of formula (I), or a pharmaceutically acceptable salt and / or solvate (including a hydrate) thereof; and the use of a compound of formula (I) in the treatment of a disease, disorder or condition mediated by TNF, or a disease, disorder or condition mediated by p38, in particular allergic and non-allergic diseases of the respiratory tract, more particularly obstructive or inflammatory diseases of the respiratory tract, preferably chronic obstructive pulmonary disease.

NI200700039A 2004-08-12 2007-02-09 DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS. NI200700039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0418015A GB0418015D0 (en) 2004-08-12 2004-08-12 New compounds

Publications (1)

Publication Number Publication Date
NI200700039A true NI200700039A (en) 2008-03-07

Family

ID=33017410

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200700039A NI200700039A (en) 2004-08-12 2007-02-09 DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS.

Country Status (9)

Country Link
CN (1) CN101006087B (en)
GB (1) GB0418015D0 (en)
ME (1) ME01360B (en)
NI (1) NI200700039A (en)
PE (1) PE20060618A1 (en)
RS (1) RS50642B (en)
TW (1) TWI295926B (en)
UA (1) UA93032C2 (en)
ZA (1) ZA200700923B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2303267T3 (en) * 2008-02-04 2013-11-29 Pfizer Ltd Polymorphic form of a [1, 2, 4] triazolo [4, 3-a]pyridine derivative for treating inflammatory diseases
AU2010215261A1 (en) * 2009-02-17 2011-09-08 Chiesi Farmaceutici S.P.A. Triazolopyridine derivatives as p38 MAP kinase inhibitors
GB201009731D0 (en) * 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
PE20141370A1 (en) * 2011-12-09 2014-10-17 Chiesi Farma Spa KINASE INHIBITORS
CN105693716A (en) * 2016-03-01 2016-06-22 孙霖 Crystal form A and preparing method
CN105646484A (en) * 2016-03-01 2016-06-08 孙霖 Crystal form B and preparation method

Also Published As

Publication number Publication date
ZA200700923B (en) 2008-09-25
TWI295926B (en) 2008-04-21
UA93032C2 (en) 2011-01-10
CN101006087A (en) 2007-07-25
GB0418015D0 (en) 2004-09-15
ME01360B (en) 2010-06-30
PE20060618A1 (en) 2006-07-14
TW200610529A (en) 2006-04-01
CN101006087B (en) 2010-09-29
RS50642B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
CR8918A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
ECSP088902A (en) DERIVATIVES OF PIRAZOLO [3,4-D] -PIRIMIDINE USEFUL TO TREAT RESPIRATORY DISORDERS
PA8537901A1 (en) DERIVATIVES OF USEFUL ETERES AS INHIBITING AGENTS OF THE ISOZIMAS PDE4
NO20076561L (en) Imidazoquinolines as Lipid Kinase Inhibitors
SE0200356D0 (en) Novel use
NO20082000L (en) Pyrimidinamide Compounds as PGDS Inhibitors
NO20072920L (en) Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
NO20051726L (en) Pyrimidinone derivatives as therapeutic agents for acute and chronic inflammatory, ischemic and remodeling processes
EA201200876A1 (en) NEW ANTAGONISTS CCR2 RECEPTOR AND THEIR APPLICATION
NI200700039A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS.
ATE517896T1 (en) P38 KINASE INHIBITORS
NO20052591L (en) Pyridopyrolizine and pyridoindolizine derivatives
NI201100062A (en) INHIBITORS OF MITOGEN-ACTIVATED PROTEIN KINASE ENZYMES P38.
EA201400521A1 (en) HETEROCYCLIC COMPOUNDS, MEDICINES CONTAINING THE INDICATED COMPOUNDS, THEIR USE AND METHODS OF THEIR RECEIVING
NO20081480L (en) Combination of compounds that can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
TW200720236A (en) Organic compounds
UY30935A1 (en) COMBINATION: -ANTAGONIST OF THE CHEMIOQUINE RECEIVER 1 (CCR1) -AGONIST OF THE GLUCOCORTICOID RECEPTOR- OPTIONALLY AGONIST B (BETA) 2, - PHARMACEUTICAL COMPOSITION CONTAINING IT - APPLICATIONS.
NO20065757L (en) purine derivatives
UY29057A1 (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
NO20081483L (en) Combination of compounds that can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
EA201100422A1 (en) (PHENYL) AMIDA 7- (PIPERAZIN-1-ILMETHYL) -1H-INDOL-2-CARBIC ACID AND RELATED CONNECTIONS AS P38 MAR-KINASE INHIBITORS FOR THE TREATMENT OF DISEASES
DOP2005000152A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
ATE444754T1 (en) USE OF TYROSINKINASE INHIBITORS TO TREAT INFLAMMATORY PROCESSES
ATE289812T1 (en) AZOLYLCARBYNOL DERIVATIVES OF ARYL (OR HETEROARYL) FOR THE TREATMENT OF RESPIRATORY DISEASES
EA200970422A1 (en) ANALOGUE PYRAZOLE